Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte – Trademark Portfolio
Entity Type: 03
Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TISSEEL. The owner is based in WIEN, POSTFACH.
Industriestrasse 67
WIEN, POSTFACH A-1220 , AT
Showing of trademarks Trademarks
Trademark Classifications
Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte have?
Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte file in?
Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte's most well-known trademarks?
Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte's registered trademark portfolio includes well-known marks such as TISSEEL. These are among 1 currently registered trademark in the portfolio.
What is Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte's trademark registration success rate?
Immuno, Aktiengesellschaft fur Chemischmedizinische Produkte has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.